ASP Coalition Statement for MFN Demonstration
Part B ASP Coalition Strongly Opposes CMMI’s New Part B “Most-Favored-Nation” Demonstration
Today the Part B Access for Seniors and Physicians (ASP) Coalition, which represents more than 300 patient and provider organizations across the country, released the following statement opposing the Center for Medicare & Medicaid Innovation’s (CMMI) new Part B Most-Favored-Nation (MFN) demonstration, the Global Benchmark for Efficient Drug Pricing (GLOBE) Model:
Our members strongly oppose CMMI’s new mandatory demonstration, which would fundamentally change how Medicare Part B drugs are accessed and delivered without sufficient transparency or safeguards for the sickest patients.
Americans are more concerned than ever about healthcare affordability and accessibility. Instead of implementing policies that would limit treatment options for the most vulnerable patients, we should strengthen and expand patient-centered care, improve access to life-saving therapies, and support frontline providers in caring for their communities. Tying U.S. prices to those set by foreign governments, where patients often face restrictions and serious treatment delays, ties American providers’ hands and destabilizes critical care. This type of price setting risks devastating consequences for America’s rural, underserved, and aging patients.
We urge the Administration to instead pursue solutions that lower costs while expanding access, driving American innovation, and maintaining physicians’ ability to deliver high quality, patient-centered care. Americans who depend on Part B-covered medicines deserve nothing less.
About the ASP Coalition
The Part B ASP Coalition is a coalition of more than 300 patient advocacy organizations, physician groups, and provider organizations committed to ensuring timely access to physician-administered therapies for Medicare patients. It has consistently raised concerns about MFN-style policies, including recent efforts to apply MFN pricing through executive action and in legislation.